Most patients (81%) required hospital treatment, and 7% of those needed intensive care. Forty patients were put on mechanic ventilation. Hydroxychloroquine was administered to 85% of the patients, less than half (40%) were treated with lopinavir/ritonavir combination, one third with steroids, while tocilizumab and interferon were administered to 10% and 5% of the patients respectively.
Several important differences were noted between dialysed and transplanted patients with COVID-19. Transplanted patients were significantly younger, but significantly more often presented with a severe form of COVID-19 which required hospitalization and intensive care. They were more often treated with hydroxychloroquine, steroids and tocilizumab than dialysed patients. The recovery rate was significantly higher, and the mortality rate significantly lower in transplanted than in dialysed patients (Figure 3).